The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans
Open Access
- 1 September 2011
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 121 (9), 3635-3644
- https://doi.org/10.1172/jci45790
Abstract
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene polymorphisms are associated with many autoimmune diseases. The major risk allele encodes an R620W amino acid change that alters B cell receptor (BCR) signaling involved in the regulation of central B cell tolerance. To assess whether this PTPN22 risk allele affects the removal of developing autoreactive B cells, we tested by ELISA the reactivity of recombinant antibodies isolated from single B cells from asymptomatic healthy individuals carrying one or two PTPN22 risk allele(s) encoding the PTPN22 R620W variant. We found that new emigrant/transitional and mature naive B cells from carriers of this PTPN22 risk allele contained high frequencies of autoreactive clones compared with those from non-carriers, revealing defective central and peripheral B cell tolerance checkpoints. Hence, a single PTPN22 risk allele has a dominant effect on altering autoreactive B cell counterselection before any onset of autoimmunity. In addition, gene array experiments analyzing mature naive B cells displaying PTPN22 risk allele(s) revealed that the association strength of PTPN22 for autoimmunity may be due not only to the impaired removal of autoreactive B cells but also to the upregulation of genes such as CD40, TRAF1, and IRF5, which encode proteins that promote B cell activation and have been identified as susceptibility genes associated with autoimmune diseases. These data demonstrate that early B cell tolerance defects in autoimmunity can result from specific polymorphisms and precede the onset of disease.This publication has 29 references indexed in Scilit:
- Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligationNature, 2010
- IFN Regulatory Factor 5 Is Required for Disease Development in the FcγRIIB−/−Yaa and FcγRIIB−/− Mouse Models of Systemic Lupus ErythematosusThe Journal of Immunology, 2009
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell FunctionThe New England Journal of Medicine, 2009
- Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan populationTissue Antigens, 2009
- Recent Advances in the Genetics of Autoimmune DiseaseAnnual Review of Immunology, 2009
- Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell SignalingThe Journal of Immunology, 2009
- The PTPN22 R620W Polymorphism is Associated With Severe Bacterial Infections After Human Leukocyte Antigen Geno-Identical Haematopoietic Stem-Cell TransplantationsTransplantation, 2008
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple SclerosisThe New England Journal of Medicine, 2008
- CD40 ligand and MHC class II expression are essential for human peripheral B cell toleranceThe Journal of Experimental Medicine, 2007
- Linkage proof for PTPN22 , a rheumatoid arthritis susceptibility gene and a human autoimmunity geneProceedings of the National Academy of Sciences of the United States of America, 2007